Skip to content

Type 2 diabetes mellitus with obesity treated by insulin for long-term switched to semaglutide: a case report

Type 2 diabetes mellitus with obesity treated by insulin for long-term switched to semaglutide: a case report

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400092503
Enrollment
Unknown
Registered
2024-11-18
Start date
2024-11-20
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

Observation group:None

Sponsors

Fifth Affiliated Hospital, Sun Yat-Sen University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Type 2 diabetes mellitus reaching obesity; 2.Use semaglutide for hypoglycemic treatment; 3.Check in and seek medical treatment at the Fifth Affiliated Hospital,Sun Yat-sen University from2023 to 2024;

Exclusion criteria

Exclusion criteria: 1.Incomplete clinical data to be collected;

Design outcomes

Primary

MeasureTime frame
Evaluation of the therapeutic effect of semaglutide;

Secondary

MeasureTime frame
The effect of different therapeutic doses of semaglutide on body weight;

Countries

China

Contacts

Public ContactChen Yangli

Fifth Affiliated Hospital, Sun Yat-Sen University

chenyangli_1030@163.com+86 756 2528741

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026